
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.13 | 3.13 | 0.00 |
Shares | 96.87 | 96.87 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.61 | 18.98 |
Price to Book | 3.76 | 4.25 |
Price to Sales | 1.34 | 2.32 |
Price to Cash Flow | 12.87 | 16.25 |
Dividend Yield | 1.72 | 1.16 |
5 Years Earnings Growth | 8.99 | 11.84 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.73 | 99.62 |
Consumer Defensive | 0.19 | 0.45 |
Financial Services | 0.06 | 0.63 |
Industrials | 0.01 | - |
Technology | 0.01 | 0.17 |
Number of long holdings: 419
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.65 | 795.12 | +0.36% | |
AbbVie | US00287Y1091 | 4.99 | 186.79 | +0.76% | |
UnitedHealth | US91324P1021 | 4.95 | 302.62 | +0.20% | |
J&J | US4781601046 | 4.70 | 152.01 | -0.18% | |
Abbott Labs | US0028241000 | 4.15 | 133.67 | -2.71% | |
Intuitive Surgical | US46120E6023 | 3.55 | 534.19 | +2.41% | |
Merck&Co | US58933Y1055 | 3.47 | 78.83 | -1.05% | |
Boston Scientific | US1011371077 | 2.79 | 104.58 | +0.28% | |
Amgen | US0311621009 | 2.78 | 279.11 | -0.44% | |
Thermo Fisher Scientific | US8835561023 | 2.73 | 412.12 | +0.36% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Stock Market Ins Pls | 748.58B | 0.54 | 13.73 | 12.17 | ||
Vanguard 500 Index Admiral | 560.5B | 1.05 | 14.37 | 12.82 | ||
Vanguard Total Stock Market Admiral | 399.92B | 0.53 | 13.71 | 12.15 | ||
Vanguard Total Intl Stock Index Inv | 226.68B | 13.77 | 9.10 | 5.52 | ||
Vanguard 500 Index Institutional Se | 207.44B | 1.06 | 14.40 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review